A Randomized, Double-blind, Placebo-controlled Study Of The Safety And Efficacy Of Etanercept In Subjects With Rheumatoid Arthritis Who Have Had An Inadequate Response To Adalimumab Or Infliximab Plus Methotrexate
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms SERUM
- Sponsors Pfizer
- 10 Jun 2017 Biomarkers information updated
- 22 Jul 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 16 Dec 2013 Planned End Date changed from 1 May 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.